ProfileGDS4718 / 235127_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 1% 4% 22% 2% 5% 2% 6% 2% 2% 3% 5% 3% 1% 1% 1% 14% 5% 2% 7% 1% 3% 3% 4% 3% 3% 2% 2% 2% 2% 4% 3% 2% 2% 2% 4% 2% 3% 4% 2% 14% 2% 2% 5% 2% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.394431
GSM549102patient 115, normal, homogenized [OPG study]3.531414
GSM549104patient 119, normal, homogenized [OPG study]4.1872522
GSM549108patient 138, normal, homogenized [OPG study]3.412622
GSM549119patient 077, normal, homogenized [OPG study]3.563135
GSM549133patient 032, cancer, homogenized [OPG study]3.392272
GSM549139patient 042, cancer, homogenized [OPG study]3.621626
GSM549099patient 107, normal, homogenized [OPG study]3.441242
GSM549109patient 139, normal, homogenized [OPG study]3.459892
GSM549110patient 046, normal, homogenized [OPG study]3.513823
GSM549114patient 063, normal, homogenized [OPG study]3.588225
GSM549122patient 082, normal, homogenized [OPG study]3.513263
GSM549134patient 033, cancer, homogenized [OPG study]3.2581
GSM549136patient 036, cancer, homogenized [OPG study]3.35151
GSM549140patient 044, cancer, homogenized [OPG study]3.293541
GSM549111patient 047, normal, homogenized [OPG study]3.9178314
GSM549113patient 057, normal, homogenized [OPG study]3.557435
GSM549132patient 031, cancer, homogenized [OPG study]3.397652
GSM549137patient 038, cancer, homogenized [OPG study]3.662047
GSM549142patient 047, cancer, homogenized [OPG study]3.298691
GSM549100patient 110, normal, homogenized [OPG study]3.488823
GSM549107patient 135, normal, homogenized [OPG study]3.473983
GSM549115patient 068, normal, homogenized [OPG study]3.521984
GSM549116patient 072, normal, homogenized [OPG study]3.476553
GSM549120patient 078, normal, homogenized [OPG study]3.503973
GSM549131patient 030, cancer, homogenized [OPG study]3.394262
GSM549118patient 074, normal, homogenized [OPG study]3.452852
GSM549129patient 027, cancer, homogenized [OPG study]3.422652
GSM549123patient 088, normal, homogenized [OPG study]3.440082
GSM549124patient 006, cancer, homogenized [OPG study]3.532854
GSM549126patient 015, cancer, homogenized [OPG study]3.474473
GSM549128patient 025, cancer, homogenized [OPG study]3.433822
GSM549103patient 117, normal, homogenized [OPG study]3.414062
GSM549117patient 073, normal, homogenized [OPG study]3.463892
GSM549138patient 041, cancer, homogenized [OPG study]3.502794
GSM549141patient 045, cancer, homogenized [OPG study]3.392922
GSM549130patient 028, cancer, homogenized [OPG study]3.465683
GSM549101patient 111, normal, homogenized [OPG study]3.546554
GSM549105patient 128, normal, homogenized [OPG study]3.392772
GSM549106patient 134, normal, homogenized [OPG study]3.8948814
GSM549112patient 048, normal, homogenized [OPG study]3.440842
GSM549125patient 011, cancer, homogenized [OPG study]3.397332
GSM549127patient 024, cancer, homogenized [OPG study]3.546625
GSM549135patient 035, cancer, homogenized [OPG study]3.363232